SecBot SecBot
8-K ·Filed Apr 30, 2026

EHC

Encompass Health Corp
BULLISH
Impact 7/10
Horizonweeks Processed6mo ago SEC0000785161-26-000128
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The beat-and-raise quarter with accelerating revenue growth, margin expansion, and strong cash flow supports a bullish thesis. Watch for continued same-store discharge trends and de novo hospital openings as catalysts. The raised guidance midpoint implies ~7% revenue growth and ~7% adjusted EBITDA growth for the remainder of 2026.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$107.38
T+0 close · Apr 30, 2026 · via day close
Latest settled
+6.05%
T+60 · $113.88
Vs SPY
+3.49%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $107.38entry
  2. T+1 · 7mo ago −1.03%α −0.69% · $106.27
  3. T+5 · 6mo ago −1.16%α −3.51% · $106.13
  4. T+20 · 6mo ago −4.83%α −10.10% · $102.19
  5. T+60 · 4mo ago +6.05%α +3.49% · $113.88

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Encompass Health reported Q1 2026 results with net operating revenue of $1.5866B (+9.0% YoY) and GAAP diluted EPS from continuing operations of $1.77 (+19.6% YoY), beating consensus estimates of $1.51 EPS and $1.57B revenue. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and adjusted EPS, signaling continued operational momentum and capacity expansion.

Key Financial Metrics

EPS
$1.77
est $1.51 · +17.2%
Revenue
$1.6B
est $1.6B · +1.1% · +9.0% YoY
Rating
strong beat
Guidance
$6.375B-$6.470B
raised
Free Cash Flow
$193.8M

Key Facts

  • Q1 2026 net operating revenue $1.5866B, up 9.0% YoY from $1.4554B
  • GAAP diluted EPS from continuing operations $1.77, up 19.6% YoY from $1.48
  • Adjusted EPS $1.60, up 16.8% YoY from $1.37
  • Adjusted EBITDA $348.8M, up 11.2% YoY from $313.6M
  • Full-year 2026 guidance raised: revenue to $6.375B-$6.470B (from $6.365B-$6.465B), Adjusted EBITDA to $1.350B-$1.380B (from $1.340B-$1.380B), adjusted EPS to $5.89-$6.11 (from $5.81-$6.10)
  • Total discharges up 4.3% YoY to 67,763; same-store discharge growth 1.6%
  • Net patient revenue per discharge $22,633, up 3.7% YoY
  • Repurchased 707,965 shares for $71.6M in Q1; $261M remaining under buyback authorization
  • Net leverage 1.9x; amended credit agreement extended to March 2031
  • Opened 49-bed hospital in Irmo, SC; added 44 beds to existing hospitals

Financial Impact

Revenue beat consensus by ~$16.6M (1.06%); EPS beat consensus by $0.26 (17.2%)

revenueepsadjustedEbitdadischargesguidance

Risk Factors

  • Same-store discharge growth decelerated to 1.6% from 4.4% in Q1 2025, signaling potential market saturation or competitive pressure
  • Adjusted free cash flow declined 12.9% YoY to $193.8M due to higher working capital and maintenance capex
  • Medicaid supplemental payments contributed $15.3M to other revenue, including $4.9M from prior periods, not fully recurring
  • Provider tax expenses increased $9.7M YoY, pressuring margins
  • RCD and TEAM regulatory programs introduce reimbursement uncertainty for Medicare patients

Market Snapshot

Exchange
NYSE
Sector
Services-Hospitals
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000785161-26-000128
Document: ehcq12026earningsslides_.htm0000785161-26-000128
Document: ehc-20260430.htm0000785161-26-000128
Document: 0000785161-26-000128-index-headers.html0000785161-26-000128
Document: 0000785161-26-000128-index.html0000785161-26-000128
Document: 0000785161-26-000128.txt0000785161-26-000128
8-K Data (Synthetic)0000785161-26-000128

Track record

14 reports on EHC

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +8.88% at T+60 after the Aug 5, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago 8-K Neutral 4/10 Entry $137.54 to $141.15 Now $142.11 +3.32% ▲ +2.62% +0.26% vs SPY
  2. Oct 28, 202619d ago 8-K Bullish 6/10 No price data
  3. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $131.49 to $135.90 Now $142.11 +8.08% ▲ +3.35% +5.13% vs SPY
  4. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $122.09 to $131.49 Now $142.11 +16.40% ▲ +7.70% +8.08% vs SPY
  5. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $124.09 to $124.10 Now $142.11 +14.52% ▲ +0.01% −0.70% vs SPY
  6. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $126.01 to $124.09 Now $142.11 +12.78% ▼ −1.52% −1.00% vs SPY
  7. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $119.80 to $120.97 Now $142.11 +18.62% ▲ +0.98% +0.30% vs SPY
  8. Sep 1, 202610w ago Insider Cluster Neutral 3/10 Entry $122.05 to $121.18 Now $142.11 +16.44% ▼ −0.71% −1.16% vs SPY
  9. Aug 11, 202613w ago Insider Cluster Bearish 5/10 Entry $125.35 to $124.83 Now $142.11 −13.37% ▲ +0.41% +0.67% vs SPY
  10. Aug 5, 202614w ago Press Release Bullish 7/10 Entry $124.82 to $125.23 Now $142.11 +13.85% ▲ +0.33% −0.28% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 8h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026